CytoSorbents Receives M in Non-Dilutive Debt Financing from Bridge Financial institution and Extends Mortgage Settlement

CytoSorbents Receives $5M in Non-Dilutive Debt Financing from Bridge Financial institution and Extends Mortgage Settlement

Non-dilutive debt capital at market favorable phrases strengthens the steadiness sheet and offers extra working capital to fund key scientific and industrial initiatives PRINCETON, N.J., Dec. 29, 2022 /PRNewswire/ — CytoSorbents Company (NASDAQ: CTSO), a frontrunner within the therapy of life-threatening circumstances within the intensive care unit and cardiac surgical procedure utilizing blood purification through its proprietary […]

Continue Reading